ORAMED PHARMACEUTICALS INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

ORAMED PHARMACEUTICALS INC. reported Cash And Cash Equivalents At Carrying Value of $45.95 million for the year ending 2025.

  • ORAMED PHARMACEUTICALS INC. showed a decrease of -15.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from ORAMED PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2011 to 2025), ORAMED PHARMACEUTICALS INC.'s Cash And Cash Equivalents At Carrying Value has grown by 2,936.8%.
  • Historical annual values: Fiscal year 2025: $45.95 million | Fiscal year 2024: $54.42 million | Fiscal year 2023: $9.06 million | Fiscal year 2022: $40.46 million | Fiscal year 2021: $77.25 million | Fiscal year 2020: $19.30 million | Fiscal year 2019: $3.33 million | Fiscal year 2018: $5.00 million | Fiscal year 2017: $3.97 million | Fiscal year 2016: $3.91 million | Fiscal year 2015: $3.21 million | Fiscal year 2014: $1.76 million | Fiscal year 2013: $2.27 million | Fiscal year 2012: $4.43 million | Fiscal year 2011: $1.51 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: